IVC logo

Invacare Corporation (IVC) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

0.66$'dan işlem gören Invacare Corporation (IVC), 25M değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 42/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 8 Şub 2026
42/100 AI Puanı PD 25M

Invacare Corporation (IVC) Sağlık ve Boru Hattı Genel Bakışı

CEOMatthew E. Monaghan
Çalışanlar3000
MerkezElyria, OH, US
Halka Arz Yılı1984
SektörHealthcare

Invacare Corporation, a global leader in home medical equipment, offers a comprehensive range of mobility, lifestyle, and respiratory products, serving diverse customer segments through multiple channels, but faces challenges with profitability and market capitalization in a competitive landscape.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 8 Şub 2026

Yatırım Tezi

Investing in Invacare Corporation presents a speculative opportunity, given its current market capitalization of $0.02 billion and negative profitability metrics, including a P/E ratio of -0.24 and a profit margin of -13.6%. The company's established presence in the medical equipment market and diverse product portfolio offer potential for revenue growth, particularly in the expanding home healthcare sector. A key value driver is Invacare's ability to innovate and introduce new products that meet the evolving needs of its customer base. Upcoming catalysts include potential improvements in operational efficiency and cost management, which could lead to enhanced profitability. However, investors should carefully consider the risks associated with the company's financial performance and competitive landscape before making an investment decision. Successful execution of turnaround strategies and adaptation to market dynamics are critical for realizing the company's potential.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market capitalization of $0.02 billion reflects its small size and potential volatility.
  • Negative P/E ratio of -0.24 indicates current unprofitability.
  • Profit margin of -13.6% highlights significant challenges in achieving profitability.
  • Gross margin of 23.6% suggests potential for improvement through cost management and pricing strategies.
  • No dividend yield reflects the company's current financial constraints and focus on reinvestment.

Rakipler & Benzerleri

Güçlü Yönler

  • Diverse product portfolio
  • Established brand presence
  • Extensive distribution network
  • Long-standing industry experience

Zayıflıklar

  • Low market capitalization
  • Negative profitability metrics
  • High debt levels
  • Intense competition

Katalizörler

  • Ongoing: Implementation of cost reduction initiatives to improve profitability.
  • Upcoming: Potential new product launches in the mobility and respiratory therapy segments.
  • Ongoing: Expansion of distribution channels to reach new customer segments.
  • Upcoming: Strategic partnerships to enhance market access and product offerings.

Riskler

  • Ongoing: Intense competition from established and emerging players.
  • Potential: Economic downturns affecting healthcare spending.
  • Potential: Changes in healthcare regulations impacting reimbursement rates.
  • Ongoing: Technological disruptions rendering existing products obsolete.
  • Potential: Product liability claims and recalls.

Büyüme Fırsatları

  • Expansion in the Home Healthcare Market: The global home healthcare market is projected to reach $367.2 billion by 2028, growing at a CAGR of 7.9% from 2021. Invacare can capitalize on this trend by expanding its product offerings and distribution channels to cater to the growing demand for home-based medical equipment and services. Focus on remote patient monitoring and telehealth solutions can further enhance its market position.
  • Product Innovation and Development: Investing in research and development to introduce innovative products that address unmet needs in the market is crucial. Focus on developing smart medical devices with remote monitoring capabilities and user-friendly designs can attract a wider customer base and enhance brand loyalty. This includes advanced mobility solutions and respiratory therapy equipment.
  • Strategic Partnerships and Acquisitions: Forming strategic partnerships with healthcare providers, technology companies, and distributors can expand Invacare's reach and market access. Acquisitions of complementary businesses can add new product lines and capabilities, strengthening its competitive position. This can lead to synergies and cost savings.
  • Geographic Expansion: Expanding into emerging markets with high growth potential can drive revenue growth. Focus on countries with aging populations and increasing healthcare spending can provide significant opportunities. Adapting products and services to meet the specific needs of local markets is essential for success.
  • Enhanced Digital Marketing and E-commerce: Strengthening its digital marketing efforts and e-commerce platform can improve customer engagement and drive online sales. Investing in search engine optimization, social media marketing, and targeted advertising can increase brand awareness and attract new customers. A user-friendly e-commerce platform can enhance the customer experience and facilitate online purchases.

Fırsatlar

  • Expansion in the home healthcare market
  • Product innovation and development
  • Strategic partnerships and acquisitions
  • Geographic expansion

Tehditler

  • Economic downturns
  • Changes in healthcare regulations
  • Technological disruptions
  • Increased competition

Rekabet Avantajları

  • Established brand recognition in the medical equipment market.
  • Diverse product portfolio catering to various healthcare needs.
  • Extensive distribution network reaching multiple customer segments.
  • Long-standing history and experience in the industry.

IVC Hakkında

Founded in 1885 and headquartered in Elyria, Ohio, Invacare Corporation has evolved into a global provider of medical equipment designed for home healthcare, retail, and extended care environments. The company's extensive product portfolio encompasses mobility and seating solutions, including power wheelchairs under the Invacare TDX brand and custom manual wheelchairs marketed under the Invacare, Invacare Top End, and Küschall brands. These offerings are complemented by seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand. Invacare also provides a range of lifestyle products, such as pressure-relieving overlays and mattress systems under the Invacare Softform and microAIR brands, safe patient handling equipment under the Birdie, Evo, and ISA brands, residential and institutional care beds, and personal care products. Furthermore, Invacare offers respiratory therapy products, including stationary and portable oxygen concentrators under the Platinum and Perfecto2 brands, as well as the Invacare HomeFill oxygen system. Beyond product sales, the company provides repair, equipment rental, and external contracting services. Invacare distributes its products through home medical equipment providers, retail and e-commerce channels, residential care operators, dealers, and government health service customers, utilizing a combination of its sales force, independent manufacturers' representatives, and distributors.

Ne Yaparlar

  • Designs and manufactures power wheelchairs under the Invacare TDX brand.
  • Produces custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names.
  • Offers seating and positioning products under the Invacare brand.
  • Provides pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands.
  • Manufactures safe patient handling products under the Birdie, Evo, and ISA brands.
  • Offers stationary and portable oxygen concentrators under the Platinum and Perfecto2 brands.
  • Provides repair, equipment rentals, and external contracting services.
  • Distributes heart rate monitors, thermometers, and nebulizers.

İş Modeli

  • Designs, manufactures, and sells medical equipment for home healthcare, retail, and extended care markets.
  • Generates revenue through direct sales, retail channels, and e-commerce platforms.
  • Offers repair, equipment rental, and external contracting services for additional income.
  • Distributes products through a network of home medical equipment providers, dealers, and government health service customers.

Sektör Bağlamı

Invacare operates within the medical instruments and supplies industry, a sector driven by an aging global population, increasing prevalence of chronic diseases, and growing demand for home healthcare solutions. The market is characterized by intense competition, with established players and emerging companies vying for market share. Key trends include technological advancements in medical devices, a shift towards remote patient monitoring, and increasing adoption of telehealth services. Invacare's position in the industry is challenged by its current financial performance, requiring strategic initiatives to enhance competitiveness and capitalize on market opportunities. Competitors like AKU, ANPC, CYTH, ELUT, and FRLN also vie for market share within this landscape.

Kilit Müşteriler

  • Home medical equipment providers
  • Retail and e-commerce channels
  • Residential care operators
  • Dealers
  • Government health service customers
AI Güveni: 70% Güncellendi: 8 Şub 2026

Finansallar

Grafik & Bilgi

Invacare Corporation (IVC) hisse senedi fiyatı: $0.66 (+0.00, +0.00%)

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

IVC için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

IVC için Wall Street fiyat hedefi analizi.

MoonshotScore

42/100

Bu puan ne anlama geliyor?

MoonshotScore, IVC'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

IVC Healthcare Hisse Senedi SSS

IVC için değerlendirilmesi gereken temel faktörler nelerdir?

Invacare Corporation (IVC) şu anda yapay zeka skoru 42/100, düşük puanı gösteriyor. Temel güçlü yan: Diverse product portfolio. İzlenmesi gereken birincil risk: Ongoing: Intense competition from established and emerging players.. Bu bir finansal tavsiye değildir.

IVC MoonshotScore'u nedir?

IVC şu anda MoonshotScore'da 42/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

IVC verileri ne sıklıkla güncellenir?

IVC fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler IVC hakkında ne diyor?

IVC için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

IVC'a yatırım yapmanın riskleri nelerdir?

IVC için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Intense competition from established and emerging players.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

IVC'ın P/E oranı nedir?

IVC için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için IVC'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

IVC aşırı değerli mi, yoksa düşük değerli mi?

Invacare Corporation (IVC)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

IVC'ın temettü verimi nedir?

Invacare Corporation (IVC) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Fiyat itibarıyla Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Stock data pending update.
  • Financial data based on publicly available information.
  • Investment decisions should be based on individual risk tolerance and financial goals.
Veri Kaynakları

Popüler Hisseler